-- Data Further Advance Understanding of VASCEPA®/VAZKEPA® Potential Mechanisms of Action --DUBLIN, Ireland and BRIDGEWATER, N.J., Aug. 31, 2025 (GLOBE...
Compared with tirzepatide, Wegovy® (semaglutide 2.4 mg) showed a significant 57% greater reduction in the risk of heart attack, stroke...
KFSHRC Strengthens Its Position as a Fast-Growing Destination for International Patients KFSHRC recorded a 47% surge in international patients in...
V-DIFFERENCE is first study to show that Leqvio prioritized after statins helps more patients achieve guideline low-density lipoprotein cholesterol (LDL-C)...
Phase III trial informed by comprehensive KARDIA data set generated through three Phase II studies: KARDIA-1, KARDIA-2 and KARDIA-3In the...
DELRAY BEACH, Fla., Aug. 30, 2025 /PRNewswire/ -- The global Near infrared Imaging Market, valued at US$9.69 billion in 2023, stood...
MIAMI, FL / ACCESS Newswire / August 30, 2025 / In today's fast-paced world, maintaining mental sharpness, focus, and memory...
MIAMI BEACH, FLORIDA / ACCESS Newswire / August 30, 2025 / Nutriessential, a U.S.-based professional-grade dietary supplement provider, proudly announces...
-- 2025 ESC/EAS Dyslipidemia Guideline Focused Update Reaffirms High Dose Icosapent Ethyl as Class IIA Recommended Therapy in High-Risk or...
- Acoramidis demonstrated a significant reduction in risk of CVM through 42 months post-randomization, with a 44% hazard reduction, setting...
Positive Trial Demonstrates Superiority of Aficamten to Standard-of-Care Beta-Blocker Metoprolol Primary Endpoint Result Consistent Across All Prespecified Subgroups Company to...
Not for dissemination in the United States of America VANCOUVER, British Columbia, Aug. 29, 2025 (GLOBE NEWSWIRE) -- Aja Health...
Sanofi’s Wayrilz approved in US as first BTK inhibitor for immune thrombocytopenia Novel treatment targets BTK through multi-immune modulation to...
$1.3 Million in Operating Expense Reductions Achieved– Operating Loss Improves 19% Year-Over-YearResilient Portfolio Performance with International Sales Despite Global Economic...
LEQEMBI IQLIK is the first and only anti-amyloid treatment to offer an at-home injection to help patients and care partners...
Expansion at Alliance Recovery in Orange County, CA increases treatment capacity by 16 and paves the way for a future...
PRINCETON, N.J., Aug. 29, 2025 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq: IART), a leading global medical technology company,...
VANCOUVER, BC / ACCESS Newswire / August 29, 2025 / GLG Life Tech Corporation (TSX:GLG) ("GLG" or the "Company"), a...
Highlights: Total revenue of $10.0 million for Q1 202636% gross profit margin for Q1 2026Positive Adjusted EBITDA of $0.3 million...
BOSTON, Aug. 29, 2025 /PRNewswire/ -- Ginkgo Bioworks (NYSE: DNA) today released the following notice: UNITED STATES DISTRICT COURTNORTHERN DISTRICT OF...